Research Article Details

Article ID: A16479
PMID: 28364816
Source: Clin Liver Dis
Title: De Novo and Recurrence of Nonalcoholic Steatohepatitis After Liver Transplantation.
Abstract: Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in developing countries. Approximately 25% of patients with NAFLD develop nonalcoholic steatohepatitis (NASH). NASH-related cirrhosis is now a leading listing indication for liver transplantation in the United States. Although posttransplant survival for NASH-related cirrhosis is comparable with that of other liver diseases, many patients have features of metabolic syndrome, which can contribute to a recurrence of NAFLD or NASH. This article reviews the epidemiology, pathophysiology, and treatment of de novo and recurrence of NASH after liver transplantation.
DOI: 10.1016/j.cld.2016.12.006